Clinical Trial Results:
A Phase 3 Randomized, Open-Label Study of Ponatinib versus Imatinib in Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Summary
|
|
EudraCT number |
2012-001355-38 |
Trial protocol |
GB DE SE BE CZ NL IT ES FI SK PT AT PL |
Global completion date |
29 Jan 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
29 Jun 2017
|
First version publication date |
29 Jun 2017
|
Other versions |
|
Summary report(s) |
AP24534-12-301 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.